Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
Status:
RECRUITING
Trial end date:
2035-07-01
Target enrollment:
Participant gender:
Summary
This is a 2-arm, noncomparative phase 2 trial designed to evaluate treatment outcomes with or without the addition of ciprofloxacin, metronidazole, and aspirin to first-line chemotherapy for patients with stage IV colorectal cancer (CRC).